CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action
Why Life-Saving Pediatric Treatments Need NIH Funding
Unlocking Hope with Improved Access to Gene Therapy
CHA Applauds HHS’ Funding Boost for Childhood Cancer Research, Urges Further Action
Children's Hospital Association encourages policymakers and leaders to keep investing in better research, innovation, and patient care for children and adolescents with cancer.
Oct. 02, 2025
Why Life-Saving Pediatric Treatments Need NIH Funding
National Institutes of Health research funding is responsible for many curative and life-enhancing medical advancements for children.
Sep. 30, 2025
Unlocking Hope with Improved Access to Gene Therapy
The promise of CGTs is tempered by their staggering cost and treatment complexity.
Sep. 23, 2025
